Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS-Reference-Cited by-同舟云学术

Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS

Published:2005-01 Issue:1-2 Volume:158 Page:222-230
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Eikelenboom M. Judith,Killestein Joep,Izeboud Thijs,Kalkers Nynke F.,Baars Paul A.,van Lier Rene A.W.,Barkhof Frederik,Uitdehaag Bernard M.J.,Polman Chris H.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference30 articles.

1. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation;Bitsch;Brain,2000

2. Distribution of immunoglobulin superfamily members ICAM-1, -2,-2 and the β2 intergin LFA-1 in multiple sclerosis lesions;Bo;J. Neuropathol. Exp. Neurol.,1996

3. The adhesion molecule and cytokine profile of multiple sclerosis lesions;Cannella;Ann. Neurol.,1995

4. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system;Cannella;J. Exp. Med.,1990

5. Differential expression of beta1 and beta2 integrins and L-selectin on CD4+ and CD8+ T lymphocytes in human blood: comparative analysis between isolated cells, whole blood samples and cryopreserved preparations;Cavers;Clin. Exp. Immunol.,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming;Cell Metabolism;2020-02

2. Metabolic and safety issues for multiple sclerosis pharmacotherapy – opportunities for personalised medicine;Expert Opinion on Drug Metabolism & Toxicology;2014-06-09

3. Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis;Expert Opinion on Drug Metabolism & Toxicology;2013-05-17

4. Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis;PLoS ONE;2012-02-20

5. Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis;PLoS ONE;2011-12-27